These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 9739013

  • 1. A two-color BCR-ABL probe that greatly reduces the false positive and false negative rates for fluorescence in situ hybridization in chronic myeloid leukemia.
    Grand FH, Chase A, Iqbal S, Nguyen DX, Lewis JL, Marley SB, Davidson RJ, Goldman JM, Gordon MY.
    Genes Chromosomes Cancer; 1998 Oct; 23(2):109-15. PubMed ID: 9739013
    [Abstract] [Full Text] [Related]

  • 2. Factors influencing the false positive and negative rates of BCR-ABL fluorescence in situ hybridization.
    Chase A, Grand F, Zhang JG, Blackett N, Goldman J, Gordon M.
    Genes Chromosomes Cancer; 1997 Apr; 18(4):246-53. PubMed ID: 9087564
    [Abstract] [Full Text] [Related]

  • 3. Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.
    Wu B, Zhou S, Song L, Liu X.
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):364-6. PubMed ID: 12408765
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [A molecular cytogenetic study on chromosome anomalies of chronic myeloid leukemia].
    Zhu B, Shen X, Li C, Lai X, Li Y, Shi K, Feng H, Wang R.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):116-8. PubMed ID: 10751535
    [Abstract] [Full Text] [Related]

  • 8. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia].
    Qiu HR, Miao KR, Wang R, Qiao C, Zhang JF, Zhang SJ, Qian SX, Xu W, Li JY.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):207-10. PubMed ID: 19350518
    [Abstract] [Full Text] [Related]

  • 9. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
    Primo D, Tabernero MD, Rasillo A, Sayagués JM, Espinosa AB, Chillón MC, Garcia-Sanz R, Gutierrez N, Giralt M, Hagemeijer A, San Miguel JF, Orfao A.
    Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
    [Abstract] [Full Text] [Related]

  • 10. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11.
    Sessarego M, Fugazza G, Bruzzone R, Ballestrero A, Miglino M, Bacigalupo A.
    Haematologica; 2000 Jan; 85(1):35-9. PubMed ID: 10629589
    [Abstract] [Full Text] [Related]

  • 11. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes.
    Reid AG, Tarpey PS, Nacheva EP.
    Genes Chromosomes Cancer; 2003 Jul; 37(3):282-90. PubMed ID: 12759926
    [Abstract] [Full Text] [Related]

  • 12. High reliability and sensitivity of the BCR/ABL1 D-FISH test for the detection of BCR/ABL rearrangements.
    Pelz AF, Kröning H, Franke A, Wieacker P, Stumm M.
    Ann Hematol; 2002 Mar; 81(3):147-53. PubMed ID: 11904740
    [Abstract] [Full Text] [Related]

  • 13. Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis.
    Aoun P, Wiggins M, Pickering D, Foran J, Rasheed H, Pavletic SZ, Sanger W.
    Cancer Genet Cytogenet; 2004 Oct 15; 154(2):138-43. PubMed ID: 15474149
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Generation of the BCR/ABL fusion gene in a Philadelphia chromosome-negative chronic myeloid leukaemia: insertion of 5.6 Mb of 9q34 into the BCR region of chromosome 22.
    Valle L, Fernández V, Pérez-Pons C, Sánchez FG, Benítez J, Urioste M.
    Hematol Oncol; 2006 Jun 15; 24(2):86-8. PubMed ID: 16598834
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Comparison and significance of DCDF probe and ES probe in the detection of BCR/ABL fusion gene].
    DU QH, YING Y, CHEN XY, LI QS, WANG SQ, MO WJ.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Apr 15; 28(2):220-2. PubMed ID: 21462140
    [Abstract] [Full Text] [Related]

  • 18. BCR/ABL rearrangement in two cases of Philadelphia chromosome negative chronic myeloid leukemia: deletion on the derivative chromosome 9 may or not be present.
    Batista DA, Hawkins A, Murphy KM, Griffin CA.
    Cancer Genet Cytogenet; 2005 Dec 15; 163(2):164-7. PubMed ID: 16337861
    [Abstract] [Full Text] [Related]

  • 19. [Dual-color/dual-fusion interphase fluorescence in situ hybridization probe for monitoring tumor load during imatinib therapy for chronic myeloid leukemia].
    DU QF, Zhang S, Liu XL, Meng FY.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan 15; 30(1):123-5. PubMed ID: 20118001
    [Abstract] [Full Text] [Related]

  • 20. Interpretation of submicroscopic deletions of the BCR or ABL gene should not depend on extra signal-FISH: problems in interpretation of submicroscopic deletion of the BCR or ABL gene with extra signal-FISH.
    Kim YR, Cho HI, Yoon SS, Park S, Kim BK, Lee YK, Chun H, Kim HC, Lee DS.
    Genes Chromosomes Cancer; 2005 May 15; 43(1):37-44. PubMed ID: 15723338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.